Mazzola, Jr.; Robert D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mazzola, Jr.; Robert D..The latest application filed is for "3-(1h-pyrazol-4-yl)pyridine allosteric modulators of the m4 muscarinic acetylcholine receptor".

Company Profile

16.31.29

Mazzola, Jr.; Robert D. - Stewartsville NJ
MAZZOLA, JR.; Robert D. - Rahway PA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,339,156 - Acton, III , et al. May 24, 2	2022-05-24
Heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,319,298 - Bao , et al. May 3, 2	2022-05-03
6,5-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,230,556 - Gao , et al. January 25, 2	2022-01-25
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20210395224 - Acton, III; John J. ; et al.	2021-12-23
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20210380580 - ACTON, III; John J. ; et al.	2021-12-09
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,149,036 - Acton, III , et al. October 19, 2	2021-10-19
5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,981,902 - Bao , et al. April 20, 2	2021-04-20
Azabicyclo[4.1.0]heptane allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,945,771 - Clausen , et al. March 16, 2	2021-03-16
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,933,056 - Acton, III , et al. March 2, 2	2021-03-02
6,6-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,836,775 - Gao , et al. November 17, 2	2020-11-17
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200207758 - ACTON, III; John J. ; et al.	2020-07-02
5-(pyridin-3-yl)oxazole Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200109137 - BAO; Jianming ; et al.	2020-04-09
6,5-fused Heteroaryl Piperidine Ether Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200095261 - GAO; Xiaolei ; et al.	2020-03-26
Azabicyclo[4.1.0]heptane Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200095262 - CLAUSEN; Dane James ; et al.	2020-03-26
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200069671 - Acton, III; John J. ; et al.	2020-03-05
Heteroaryl Piperidine Ether Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190315708 - BAO; Jianming ; et al.	2019-10-17
6,6-fused Heteroaryl Piperidine Ether Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190315762 - GAO; Xiaolei ; et al.	2019-10-17
6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,351,564 - Gao , et al. July 16, 2	2019-07-16
6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,329,289 - Bao , et al.	2019-06-25
6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190062331 - BAO; JIANMING ; et al.	2019-02-28
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190000824 - Acton, III; John J. ; et al.	2019-01-03
6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20170183342 - BAO; JIANMING ; et al.	2017-06-29
Quinoxalines and AZA-quinoxalines as CRTH.sub.2 receptor modulators Grant 9,469,615 - Boyce , et al. October 18, 2	2016-10-18
Heterocyclic Aspartyl Protease Inhibitors App 20150105354 - Zhu; Zhaoning ; et al.	2015-04-16
Silyl-containing Heterocyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20150057246 - Dwyer; Michael P. ; et al.	2015-02-26
Quinazolinone-type compounds as CRTH.sub.2 antagonists Grant 8,927,559 - Aslanian , et al. January 6, 2	2015-01-06
Silyl-containing Heterocyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20140378416 - Dwyer; Michael P. ; et al.	2014-12-25
Heterocyclic aspartyl protease inhibitors Grant 8,829,036 - Zhu , et al. September 9, 2	2014-09-09
Heterocyclic aspartyl protease inhibitors Grant 8,691,831 - Zhu , et al. April 8, 2	2014-04-08
Heterocyclic aspartyl protease inhibitors Grant 8,691,833 - Zhu , et al. April 8, 2	2014-04-08
Quinoxalines And Aza-quinoxalines As Crth2 Receptor Modulators App 20130303517 - Boyce; Christopher W. ; et al.	2013-11-14
Gamma secretase modulators Grant 8,518,975 - Aslanian , et al. August 27, 2	2013-08-27
Quinazolinone-type Compounds As Crth2 Antagonists App 20130210805 - Aslanian; Robert G. ; et al.	2013-08-15
Gamma secretase modulators Grant 8,357,682 - Zhu , et al. January 22, 2	2013-01-22
Heterocyclic aspartyl protease inhibitors Grant 8,242,112 - Zhu , et al. August 14, 2	2012-08-14
Heterocyclic aspartyl protease inhibitors Grant 8,178,513 - Zhu , et al. May 15, 2	2012-05-15
Heterocyclic aspartyl protease inhibitors Grant 7,973,067 - Zhu , et al. July 5, 2	2011-07-05
Gamma Secretase Modulators App 20110053918 - Zhu; Zhaoning ; et al.	2011-03-03
Gamma Secretase Modulators For The Treatment Of Alzheimer's Disease App 20110027264 - Huang; Xianhai ; et al.	2011-02-03
Compounds for the treatment of inflammatory disorders Grant 7,879,997 - Zhu , et al. February 1, 2	2011-02-01
Gamma Secretase Modulators App 20110009392 - Zhu; Zhaoning ; et al.	2011-01-13
Gamma Secretase Modulators App 20100298381 - Zhu; Zhaoning ; et al.	2010-11-25
Gamma Secretase Modulators App 20100247514 - Zhu; Zhaoning ; et al.	2010-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.